A humanized monoclonal antibody targeting CD39 with novel mechanism for cancer treatment
ATP-adenosine signal axis plays an import role in tumor immune regulation. ATP released by tumor cells can promote antitumor immunity, and adenosine can suppress the immune response. CD39, also known as Nucleoside triphosphate diphosphohydrolase-1 (NTPDase1), can hydrolyze ATP into ADP and AMP, then...
Main Authors: | Zheng Wei, Fang Ren, Shiyong Gong, Beilei Shi, Kedong Ouyang, Chengbin Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | Medicine in Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590098621000142 |
Similar Items
-
Monoclonal Antibody Therapies against Anthrax
by: Zhaochun Chen, et al.
Published: (2011-08-01) -
What Else Can CD39 Tell Us?
by: Hai Zhao, et al.
Published: (2017-06-01) -
Elevated CD39+T-Regulatory Cells and Reduced Levels of Adenosine Indicate a Role for Tolerogenic Signals in the Progression from Moderate to Severe COVID-19
by: Alaa Elsaghir, et al.
Published: (2023-12-01) -
An Anti-CD7 Antibody–Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL)
by: Shiqi Wang, et al.
Published: (2024-01-01) -
The Role of Cluster of Differentiation 39 (CD39) and Purinergic Signaling Pathway in Viral Infections
by: Alaa Elsaghir, et al.
Published: (2023-02-01)